3-196472333-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_152617.4(RNF168):c.1202C>A(p.Pro401Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.586 in 1,613,568 control chromosomes in the GnomAD database, including 287,146 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_152617.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF168 | NM_152617.4 | c.1202C>A | p.Pro401Gln | missense_variant | 6/6 | ENST00000318037.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF168 | ENST00000318037.3 | c.1202C>A | p.Pro401Gln | missense_variant | 6/6 | 1 | NM_152617.4 | P1 | |
RNF168 | ENST00000437070.1 | c.*774C>A | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.499 AC: 75789AN: 151904Hom.: 20700 Cov.: 32
GnomAD3 exomes AF: 0.536 AC: 134718AN: 251322Hom.: 39033 AF XY: 0.554 AC XY: 75260AN XY: 135824
GnomAD4 exome AF: 0.595 AC: 869575AN: 1461548Hom.: 266449 Cov.: 47 AF XY: 0.598 AC XY: 434639AN XY: 727064
GnomAD4 genome AF: 0.499 AC: 75788AN: 152020Hom.: 20697 Cov.: 32 AF XY: 0.499 AC XY: 37046AN XY: 74298
ClinVar
Submissions by phenotype
RIDDLE syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Nov 07, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at